SLRX Salarius Pharmaceuticals

Watchlist

1.0700
+0.0450+4.39%

Trading Mar 5 13:15 ET

1.69MMarket Cap-0.21P/E (TTM)

About Salarius Pharmaceuticals Company

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.

Company Profile

SymbolSLRX

Company NameSalarius Pharmaceuticals

Listing DateJan 29, 2015

Issue Price16.00

Founded2014

CEOMr. David J. Arthur

MarketNASDAQ

Employees2

Fiscal Year Ends12-31

Address2450 Holcombe Boulevard,Suite X

CityHouston

ProvinceTexas

CountryUnited States of America

Zip Code77021

Phone1-832-834-6992

Websitehttp://salariuspharma.com

Company Executives

Name
Position
Salary

David J. Arthur
Chief Executive Officer
544.60K

Mark J. Rosenblum
Executive Vice President, Finance and Chief Financial Officer
355.76K

Dr. William K. McVicar, PhD
Chairman of the Board
82.26K

Dr. Bruce J. McCreedy, PhD
Independent Director
45.26K

Tess Burleson
Independent Director
64.76K

Jonathan I. Lieber, M.B.A.
Independent Director
53.76K

Dr. Paul Lammers, M. Sc.,M.D.
Lead Independent Director
76.76K

Arnold C. Hanish
Independent Director
67.26K

SLRX Salarius Pharmaceuticals

About Salarius Pharmaceuticals Company

Company Profile

Company Executives

Trending Stocks